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ABSTRACT
Background and Objectives: Inappropriately high left ventricular mass (iLVM) is known to be related to cardiovascular 
prognosis. A non-dipper pattern has a greater mean left ventricular (LV) mass than the dipper pattern in hypertensive patients. 
However, the appropriateness of LV mass in dipper or non-dipper patterns has not been adequately investigated. The aim of 
this study was to define the relationship between nocturnal dipping and the appropriateness of LV mass. Subjects and Methods: 
Using the ambulatory blood pressure monitoring (ABPM) database, the data of 361 patients who underwent ABPM and echo-
cardiography was analyzed retrospectively. Appropriateness of LV mass was calculated as observed/predicted ratio of LV mass 
(OPR) using a Korean-specified equation. Nocturnal dipping was expressed as percent fall in systolic blood pressure (BP) 
during the night compared to the day. Results: Daytime, nighttime and 24 hours BP in hypertensive patients was 140.4±14.8 
mmHg, 143.7±15.2 mmHg and 129.4±20.0 mmHg, respectively. OPR was 106.3±19.9% and nocturnal dipping was 10.2±10.9 
mmHg. In a multiple linear regression model, 24 hours systolic BP (β=0.097, p=0.043) and nocturnal dipping (β=-0.098, 
p=0.046) were independent determinants of OPR as well as age (β=0.130, p=0.025) and body mass index (BMI) (β=0.363, 
p<0.001). Odds ratio of the non-dipper pattern was 2.134 for iLVM (p=0.021) and 3.694 for obesity (p<0.001; BMI >25 kg/m
2). 
Conclusion: The non-dipper pattern is independently associated with iLVM in hypertensive patients as well as obesity. (Korean 
Circ J 2011;41:191-197)
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Introduction
Left ventricular hypertrophy (LVH) is a strong, indepen-
dent predictor of cardiovascular morbidity and mortality in 
hypertensive patients.
1) Left ventricular (LV) mass is influenc-
ed by hemodynamic factors, such as high blood pressure (BP) 
and stroke work, as well as numerous demographic and non-
hemodynamic factors.
2) However, a number of patients exhi-
bit levels of LV mass that exceed the need to sustain cardiac 
workload, a condition that has been defined as inappropriate-
ly high left ventricular mass (iLVM).
3)
iLVM is related to a worse cardiovascular prognosis than ap-
propriate LV mass (aLVM) in patients with or without LVH.
2) 
The iLVM may be explained by several mechanisms. Firstly, 
the presence of a higher BP load in the ascending aorta can-
not be explained by brachial BP derived resting stroke work.
3) 
Secondly, imbalance between growth-promoting factors and 
growth inhibitory factors has been suggested.
4-6) Thirdly, BP 
variability throughout the day might influence increased LV 
mass.
7) In addition, genetic factors may be responsible for ex-
aggerated or overcompensating hypertrophy to a given pres-
sure load.
8) Nonetheless, the underlying pathogenic mechanism 
is not fully understood.
9)
In addition to these mechanisms, the presence of a hidden 
higher BP load out of the clinic or during sleep which cannot 
be explained by office BP deserves attention, since non-dipper 192   Nocturnal Dipping and Inappropriately High Left Ventricular Mass
or reverse white coat effects are common clinical problems. 
Hypertensive patients with non-dipper patterns in noctur-
nal BP have heavier LV mass than those with dipper patterns. 
Patients with non-dipper patterns are also at a higher risk of 
cardiac and extracardiac morbidity.
10)11) Regarding poor prog-
nosis in non-dipper patterns however, it is unclear whether 
there are other mechanisms such as growth or genetic factors 
that simply hide BP overload during sleep. Likewise, regard-
ing the heavier LV mass in non-dipper patterns, it is also un-
clear whether heavier LV mass is due to simply hidden BP ov-
erload during sleep or due to other mechanisms related to 
the non-dipper pattern.
To better understand the mechanisms of iLVM, we hypoth-
esized that nocturnal dipping is one of the factors determining 
inappropriateness of LV mass in hypertensive patients.
Subjects and Methods
Study population and study design
In a retrospective cross-sectional design, data from 361 pa-
tients visiting the Cardiology Center at Hanyang University 
Hospital, Seoul, Korea from January 1st, 2006 to June 30th, 2010 
were analyzed. Among 1,297 patients who underwent ambu-
latory blood pressure monitoring (ABPM) and echocardiog-
raphy within 1 week interval for the evaluation of BP before 
or after anti-hypertensive medication, 361 patient datasets were 
acquired by applying exclusion criteria. The clinical data were 
incomplete and as follows; age <45 years, patients with pre-
vious history of stroke, acute myocardial infarction, patients 
with chronic renal insufficiency (serum creatinine >1.4 mg/
dL in female, >1.5 mg/dL in male), any regional wall motion 
abnormalities, grade II or more valvular regurgitation, any val-
vular stenosis, M-mode interrogation angle >10 degrees and 
cardiomyopathy based on the echocardiographic findings. 
Height, weight, clinical BP and heart rate were measured dur-
ing the study period before ABPM and echocardiography were 
performed. The study protocol was approved by the Institu-
tional Review Board (IRB) of Hanyang University Medical 
Center at Seoul. An informed consent process from each pa-
tient regarding the process of the examination and use of the 
data was made exempt by the IRB.
Blood pressure determination
Clinic BP was measured using a mercury sphygmomano-
meter as the average of at least 3 measurements by a physician 
or qualified nurse. ABPM was recorded during a routine day 
by a TM-2430 device (A&D, Saitama, Japan). The device was 
applied to the non-dominant arm and was applied for 24 
hours. BP was measured every 15 minutes during the daytime 
and every 30 minutes at nighttime, which was between 10 PM 
and 6 AM. The patients were instructed to maintain their usu-
al activities during the monitoring process and to stay calm 
when sensing the cuff inflation. Sleep and wake time were re-
corded individually according to the patient’s self-reported data. 
Nocturnal BP was defined by the narrow fixed interval me-
thod from midnight to 5 AM as nocturnal systolic/diastolic 
mean BP. Daytime BP was defined by mean systolic/diastolic 
BP between 8 AM and 9 PM. Twenty-four hour BP was defin-
ed by the following equation, (nocturnal BP×actual sleep in-
terval+daytime BP×awake interval)/24. Nocturnal systolic BP 
(NSBP) fall (mmHg) was defined as the absolute decrease in 
NSBP compared to daytime systolic BP. Nocturnal dipping (%) 
was defined by percent decrease in NSBP compared to day-
time systolic BP. When nocturnal dipping was less than 10%, 
it was defined as a non-dipper pattern. The definition of hyper-
tension was 24-hour systolic BP ≥125 mmHg or on antihyper-
tensive medication excluding the white-coat hypertension. Ac-
cording to this definition, 309 of the patients were hyperten-
sive out of the total 361 patients.
Echocardiography
Two dimensional and guided M-mode echocardiograms 
were performed on each subject by a single sonographer with 
a commercially available machine (iE33; Philips medical sys-
tem, Andover, MA, USA) using a 1-5 MHz transducer. M-
mode tracings were recorded on strip-chart paper at 50 mm/s. 
Measurements of interventricular septal thickness, posterior 
wall thickness, and LV dimensions were performed at or just 
below the mitral valve tips, by the leading edge-to-leading 
edge method, according to the American Society of Echocar-
diography recommendations.
12) LV mass was calculated by the 
following equation, {1.04×(IVSd+LVDd+PWTd)
3-LVDd
3}× 
0.8+0.6,
13) where IVSd is diastolic interventricular septum, 
LVDd is diastolic left ventricular dimension, and PWTd is dia-
stolic posterior wall thickness. We adopted the LV mass index 
by the height to highlight the effect of weight and set the cut-
off value {mean+ 2 standard deviation (SD)} for LVH as 54 
g/m
2.7 for both genders. LV end-systolic, end-diastolic, and stro-
ke volumes were calculated with the use of Teichholz’s method.
Appropriateness of left ventricular mass
Appropriateness of LV mass (aLVM) was expressed as the 
observed/predicted ratio of the LV mass (OPR). The predicted 
LV mass was calculated as previously described.
14) Briefly, the 
LV mass was predicted by the following equation acquired in 
subjects with normal body weight and BP: 54.9+7.62×height 
(m
2.7)+0.6×stroke work (g-m/beat)-13.2×gender (male=1, fe-
male=2) (constant=54.9±14.7 g, adjusted R
2=0.576, SEE= 
21.67, p=0.001). Gender effect was adjusted by the equation 
of appropriateness of LV mass. Stroke work refers to the 
work done by the ventricle to eject stroke volume into the 
aorta as a single-beat index of cardiac workload. It was calcu-
lated by the equation, stroke volume×(MEP-EDP), where MEP 
is mean ejection pressure and EDP is LV end-diastolic pres-Bae Keun Kim, et al.   193
sure.
15) In our study, using a coefficient representing the rela-
tionship between systolic BP and (MEP-EDP), stroke work is 
calculated as stroke volume×systolic BP×0.0144.
16) The cut-
off value between the iLVM and aLVM groups was 130% or 
higher for both genders.
14)
Statistical analysis
Data were expressed as frequencies and percentages for qu-
alitative variables and as the mean±SD for quantitative vari-
ables. Differences in study variables between hypertensive and 
normotensive patients were assessed with the Pearson χ2 for 
qualitative variables and the Student’s t-test was performed. 
Pearson’s correlation and Spearman’s correlation coefficients 
were calculated. Multiple regression analyses were used to 
identify significant determinants for OPR or iLVM. Anti-hy-
pertensive drug treatment was included in the multiple logi-
stic regression analysis. 
ANCOVA was used to adjust the result of comparing sub-
jects with inappropriately high or adequate LV mass for age, 
body mass index (BMI), 24 hours BP. Odds ratio of indepen-
dent variables were calculated by multiple logistic regression 
analysis. The values of 2-tailed p<0.05 were considered sta-
tistically significant. Data were analyzed using the Statistical 
Package for the Social Sciences (SPSS) 17.0 software (SPSS Inc., 
Chicago, IL, USA).
Results
General characteristics of the subjects
General characteristics of the normotensive subjects ver-
sus hypertensive patients are listed in Table 1. Among the 361 
patients of the study population, 52 (14.4%), classified as nor-
motensive, were white-coat hypertension patients and 309 
(85.6%) were classified as hypertensive patients. Among the 
309 hypertensive patients, 151 (48.9%) were on antihyperten-
sive treatment and 45 (14.6%) had diabetes mellitus (DM).
In a comparison of general characteristics between hyperten-
sive patients and normotensive subjects, the average age of 
the hypertensive patients was older (58.1±7.9 vs. 51.5±14.4 
years, p=0.02). Clinical BP, 24 hours ambulatory BP and BMI 
were higher in hypertensive patients.
Correlations between observed/predicted ratio and 
24 hours ambulatory blood pressure profile
Among general parameters, age, BMI, DM and antihyper-
tensive medication showed a correlation with OPR in hyper-
tensive patients. Twenty four hours systolic BP was positively 
associated with OPR, in contrast, clinical systolic BP was not, 
which suggested the white-coat effect. Nocturnal dipping sh-
owed an inverse relationship with OPR suggesting a protec-
Table 1. Clinical characteristics of normotensive and hypertensive 
subjects
Parameters
Normotensive
(n=52)
Hyptertensive
(n=309)
p
Age (years)   58.1±7.90 61.4±9.9 0.008
Systolic BP (mmHg) 127.8±16.4 140.2±20.4 <0.001
Diastolic BP (mmHg) 078.2±11.0 081.8±14.0 0.044
Heart rate (bpm) 067.5±10.8 069.9±13.1 0.216
BMI (kg/m
2) 23.9±3.1     24.6±3.600 0.160
OPR (%) 103.9±17.1 106.3±19.9 0.070
LVMI (g/m
2.7) 45.7±9.8 050.8±12.0 0.004
24 hours SBP (mmHg) 116.1±6.60 140.4±14.8 <0.001
Daytime SBP (mmHg) 118.8±7.60 143.7±15.2 <0.001
Nocturnal SBP (mmHg) 106.1±9.10 129.4±20.0 <0.001
NSBP fall (mmHg) 012.7±10.3 014.4±16.4 0.342
Nocturnal dipping (%) 10.4±8.6 010.2±10.9 0.646
Male/Female 21/31 119/190 0.798
Obesity (%) 17 (32.7) 123 (39.8) 0.322
DM (%) 07 (13.5) 045 (14.6) 0.835
Medication (%) 151 (48.9) <0.001
LVH (%) 10 (19.2) 108 (35.0) 0.013
iLVM (%) 06 (11.5) 053 (17.2) 0.262
Non-dipper (%) 27 (51.9) 157 (50.8) 0.882
Data are reported as mean±SD. BP: blood pressure, BMI: body mass 
index, OPR: observed/predicted ratio of LV mass, LVMI: left ven-
tricular mass index, SBP: systolic BP, LVH (LVMI ≥54.0 g/m
2.7): left 
ventricular hypertrophy, NSBP: Nocturnal SBP, DM: diabetes mel-
litus, Medication: Antihypertensive medication, iLVM: inappropri-
ate high LV mass, Obesity: BMI >25 kg/m
2
Table 2. Pearson and Spearman correlation test between OPR and 24 hours ambulatory blood pressure profile in patients (n=361) 
Parameters Clinic SBP 24 hours SBP Nocturnal SBP Nocturnal dipping LVMI OPR
Age -0.129* -0.094† -0.199† -0.232† -0.190† -0.204†
Female -0.004 -0.048 -0.004 -0.053 -0.024 -0.071
BMI -0.018 -0.086 -0.067 -0.001 -0.492† -0.394†
DM -0.018 -0.002 -0.098 -0.182† -0.119* -0.180†
Medication -0.036 -0.136† -0.137† -0.089 -0.194† -0.145†
LVMI -0.090 -0.253† -0.266† -0.125* -0.692†
OPR -0.354† -0.153† -0.214† -0.161† -0.692†
*p<0.05, †p<0.001. SBP: systolic blood pressure, BMI: body mass index, OPR: observed/predicted ratio of LV mass, DM: diabetes mellitus, 
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tive relationship (Table 2).
Multiple linear regression analysis for inappropriate 
increased LV mass (observed/predicted ratio)
In a multiple linear regression analysis for OPR of LV mass 
in all patients, age (β=0.130, p=0.025), BMI (β=0.363, p< 
0.001), 24 hours systolic BP (β=0.097, p=0.043) and noctur-
nal dipping (β=-0.098, p=0.046) were statistically significant 
parameters (Table 3). Gender was not statistically significant 
(p=0.115). 
Multiple logistic regression analysis 
for inappropriately high left ventricular mass
In all patients, odds ratio by the multiple logistic regression 
analysis for iLVM were 3.694 {95% confidence interval (CI): 
1.963-6.758, p<0.001} for obesity, and 2.192 (95% CI: 1.151-
4.177, p=0.017) for the non-dipper pattern (Table 4). Howev-
er, high 24 hours systolic BP was not statistically significant 
for iLVM.
In hypertensive patients, the odds ratio by the multiple lo-
gistic regression analysis for iLVM were 2.255 (95% CI: 1.132-
4.493, p=0.021) for age, 3.430 (95% CI: 1.781-6.604, p<0.001) 
for obesity, and 2.149 (95% CI: 1.087-4.249, p=0.028) for the 
non-dipper pattern (Table 5).
Comparsion between appropriate left ventricular 
mass and inappropriately high left ventricular mass 
group
When adjusted by age, BMI and 24 hours ssystolic BP, noc-
turnal dipping (10.8±10.6 vs. 5.7±9.9, p=0.011) was signifi-
cantly different between the aLVM and iLVM group in all pa-
tients (Fig. 1). In the hypertensive group, nocturnal dipping 
(10.7±11.0 vs. 5.7±10.0, p=0.024) was significantly different 
between the aLVM and iLVM group (Table 6) (Fig. 2)
Discussion
This study was performed for a further understanding of 
the mechanism of iLVM. Nocturnal dipping as a factor relat-
ed to OPR was the main interest. The comparison between 
the dipper and non-dipper group is out of the scope of this 
study. The main result of our study is that nocturnal dipping 
is an independent factor determining OPR in essential hyper-
tensive patients. Nocturnal dipping is significantly lower in 
the iLVM group in hypertensive patients.
Prediction of LV mass routinely preclude gender difference, 
body size, and the effect of stroke work because these factors 
Table 3. Multiple linear regression for OPR of LV mass in all pa-
tients (n=361)
Parameters β p
Age 0.130 0.025
Female 0.075 0.115
BMI 0.363 <0.001
DM -0.077 0.123
Medication 0.025 0.614
24 hours SBP 0.097 0.043
Nocturnal dipping -0.098 0.046
Dependent variable: observed/predicted ratio of LV mass. SBP: sys-
tolic blood pressure, BMI: body mass index, DM: diabetes melli-
tus, Medication: Antihypertensive medication, OPR: observed/pre-
dicted ratio, LV: left ventricular
Table 4. Multiple logistic regression for iLVM in all patients (n=361)
Parameters Odds ratio p
Age 2.487 0.006
Female 1.633 0.141
Obesity 3.642 <0.001
DM 1.459 0.328
Medication 1.505 0.200
High 24 hours SBP 1.340 0.345
Non-dipper 2.192 0.017
Dependent variable: inappropriately high left ventricular mass. SBP: 
systolic blood pressure, BMI: body mass index, OPR: observed/pre-
dicted ratio of LV mass, DM: diabetes mellitus, HTN: hypertension, 
iLVM: inappropriately high left ventricular mass
Table 5. Multiple logistic regression for iLVM in hypertensive pa-
tients (n=309)
Parameters Odds ratio p
Age 2.255 0.021
Female 1.151 0.151
Obesity 3.430 <0.001
DM 1.867 0.123
Medication 1.389 0.343
High 24 hours SBP 1.248 0.500
Non-dipper 2.149 0.028
Dependent variable: inappropriately high left ventricular mass. SBP: 
systolic blood pressure, OPR: observed/predicted ratio of LV mass, 
DM: diabetes mellitus, iLVM: inappropriately high left ventricular 
mass
Fig. 1. Adjusted Nocturnal dipping by age, BMI and 24 hours systo-
lic BP between aLVM (n=302) vs. iLVM (n=59) patients. In all pati-
ents, nocturnal dipping (10.8±10.6 vs. 5.7±9.9, p=0.011) was signi-
ficantly different in the iLVM group vs. the aLVM group. SBP: sys-
tolic blood pressure, BMI: body mass index, aLVM: appropriate left 
ventricular mass, iLVM: inappropriately high left ventricular mass.
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are included in the prediction equation derived from subjects 
with normal body weight and normal BP.
16) If it is measured 
in patients with a white-coat effect, predicted LV mass is over-
estimated so that OPR tends to be underestimated or low. On 
the contrary, OPR in patients with masked clinic BP tends 
to be higher.
Besides measurement issues, it is well known that combi-
nation of high BP and obesity biologically has a synergistic 
effect on the LVH.
17) This suggests that ambulatory BP pro-
vides a stronger relationship with LV mass increase than that 
observed in normotensive patients without obesity. Firstly, a 
stronger association between iLVM and BP might results 
from accurate BP measurement by ABPM mainly excluding 
the white-coat and reverse white-coat effect. Secondly, the 
intrinsic relationship between BP and OPR may be stronger 
in essential hypertension than in normotensive subjects. Th-
irdly, the synergistic effect of obesity and BP may amplify the 
relationship between BP and OPR. 
A previous study showed that iLVM was associated with hi-
gher ambulatory BP in hypertensive patients.
18) In this study, 
patients with iLVM had lower 24 hours systolic BP suggest-
ing that the white-coat effect was exposed by ABPM. This st-
udy revealed that 24 hours systolic BP and OPR had a weak 
independent relationship (β=0.097, p=0.043) in the multiple 
linear regression model, including age, BMI, and nocturnal 
dipping. Also, the 24 hours systolic BP was not an indepen-
dent factor determining iLVM in multiple logistic regression an-
alysis. This finding suggests that white-coat or reverse white-
coat effects were not high enough for the ABPM to expose the 
measurement problem. To further understand this issue, OPR 
defined by the equation using ambulatory BP will be helpful. 
In addition, a direct study of the relationship between white-
coat or reverse white-coat effects and iLVM seems to be nec-
essary. 
This study showed that obesity is an important determinant 
of iLVM in hypertension patients. Using multiple regression 
analysis, obesity was the strongest determinant of OPR or 
iLVM. Obesity seems to play a major role to induce inappro-
priately or excessively high LV mass, which is beyond the pro-
portional increase to BP elevation. There have been numerous 
studies for the mechanisms of obesity related to LV hyper-
trophy.
19)
In this study, effect of age itself on OPR or iLVM is just com-
parable to the 24 hours systolic BP effects or nocturnal dip-
ping. It is also much less than the obesity factor. If ageing it-
self could induce LVH, bypassing the mechanisms of obesity 
or systolic BP as well as partly including arterial stiffness, then 
this would clarify some of the controversy that surrounds this 
phenomena. This finding is consistent with the previous study 
that the effect of ageing itself is not known to be significant 
in subjects with normal BP and BMI.
16) The result of this st-
udy suggests that the main mechanisms of ageing in regard 
to inappropriateness of LV mass are mainly composed of obe-
sity, systolic BP, and potentially a non-dipper pattern. 
Regarding the mechanisms of nocturnal dipping contrib-
uting to OPR, it is less likely that decreased nocturnal dipping 
contributes to higher OPR as a hidden nocturnal hemody-
namic overload because it is independent of 24 hours ambu-
latory systolic BP. In this study, nocturnal dipping was signifi-
Table 6. Comparison between aLVM and iLVM in hypertensive 
patients
Parameters
aLVM
(n=256)
iLVM
(n=53)
p
Age (years) 60.5±9.5 065.7±10.6 0.001
Systolic BP (mmHg) 142.4±20.3 129.4±17.6 <0.001
Diastolic BP (mmHg) 081.9±14.7 081.1±10.0 0.782
Heart rate (bpm) 070.4±12.5 067.3±15.5 0.060
BMI (kg/m
2) 24.3±3.5 26.2±3.8 <0.001
OPR (%) 102.6±14.1 141.3±10.2 <0.001
LVMI (g/m
2.7) 048.2±10.5 063.5±11.0 <0.001
24 hours SBP (mmHg) 139.8±14.1 143.1±17.9 0.259
Daytime SBP (mmHg) 143.5±14.6 144.7±17.9 0.018
Nocturnal SBP (mmHg) 127.8±18.9 136.6±23.3 0.022
NSBP fall (mmHg) 015.7±16.6 008.0±14.1 0.017
Nocturnal dipping (%) 010.7±11.0 005.7±10.0 0.024
Male/Female 104/152 15/38 0.116
Medication (%) 118 (46.1)   33 (62.3) 0.281
Obesity (%) 088 (34.4) 35 (66.0) 0.032
DM (%) 029 (11.3) 16 (30.2) 0.017
LVH (%) 065 (25.4) 43 (81.1) <0.001
Non-dipper (%) 120 (46.9) 37 (69.8) 0.013
Data are reported as mean±SD and adjusted by age, BMI, 24 hours 
SBP. BP: blood pressure, BMI: body mass index, OPR: observed/
predicted ratio of LV mass, LVMI: left ventricular mass index, 
SBP: systolic BP, LVH (LVMI ≥54.0 g/m
2.7): left ventricular hypertro-
phy, Medication: Antihypertensive medication, NSBP: Nocturnal 
SBP, DM: diabetes mellitus, aLVM: appropriate LV mass, iLVM: in-
appropriate high LV mass, Obesity: BMI >25 kg/m
2
Fig. 2. Adjusted nocturnal dipping by age, BMI and 24 hours systol-
ic BP in hypertensive aLVM (n=256) vs. iLVM (n=53) patients. In the 
hypertensive patients, nocturnal dipping (10.7±11.0 vs. 5.7±10.0, p= 
0.024) was significantly different in iLVM vs. aLVM groups. SBP: sys-
tolic blood pressure, BMI: body mass index, aLVM: appropriate left 
ventricular mass, iLVM: inappropriately high left ventricular mass.
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cantly different between iLVM and aLVM group in all pa-
tients and in hypertensive patients. These findings suggest 
that nocturnal dipping may influence the appropriateness of 
LV mass by its own non-hemodynamic or intrinsic effect. 
It has been a controversy if the main mechanism of non-dip-
per as a poor prognostic marker for cardiovascular events is 
related to the nocturnal hypertension or its intrinsic effect. 
A previous study showed that non-dippers have autonomic 
dysfunction through the night and that non-dipper patterns 
were more commonly found among individuals with renal 
diseases, DM, sleep apnea and secondary hypertension.
20) 
These findings suggest that non-hemodynamic factors are 
important in manipulating nocturnal dipping. Therefore, the 
non-dipper pattern itself might be an explanation to the re-
sults of this study. However, the reproducibility of the classi-
fication of dipper and non-dipper patterns based on single 
ABPM is not reliable enough to be widely accepted.
21)
In this study, anti-hypertensive drug therapy was not an in-
dependent factor determining iLVM. The effects of anti-hy-
pertensive drugs such as the lowering of BP and regression of 
LVH in proportion have been widely reported.
22) However, 
the effect of anti-hypertensive drug classes on nocturnal BP 
has not been established. Timing of treatment is reported to 
have an influence on nocturnal BP fall in one study.
23) On the 
other hand, a recent large-scale registry study on Spanish sub-
jects showed that nocturnal dipping patterns were not asso-
ciated with the timing of treatment.
24) It is not clear whether 
anti-hypertensive drugs have an influence on the relationship 
between nocturnal BP and target organ damage. Moreover, cli-
nical consequences associated with the treatment of noctur-
nal BP have not yet been studied. To identify the beyond BP 
effect or the effect of nocturnal BP on OPR or iLVM accord-
ing to the classes of anti-hypertensive drugs, further studies 
using a larger number of subjects are needed.
There are limitations in our study. First, the details of anti-
hypertensive treatment were not surveyed in our study due 
to small sample size and incomplete data of antihypertensive 
treatment. Therefore, we could not adequately assess the spe-
cific influence of antihypertensive treatment on the noctur-
nal BP and appropriateness of LV mass. Second, the patients 
with clinical cardiovascular diseases were excluded in this 
study. Non-dipper patterns are dominant among patients with 
renal disease and severe cardiovascular disease which may 
also have an effect on nocturnal BP patterns and LV mass.
20) 
Our results cannot be applied to these complicated patients.
In conclusion, nocturnal dipping of the circadian rhythm 
of BP in addition to age, BMI, and 24 hours systolic BP de-
termine OPR in essential hypertension patients. This sup-
ports that nocturnal dipping has an intrinsic or non-hemo-
dynamic role on inappropriate LV hypertrophy which is in-
dependent of 24 hours BP.
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